Início › Câncer de Pulmão › Pensilvânia

Ensaios clínicos de Câncer de Pulmão em Pensilvânia

57 estudos para Câncer de Pulmão estão buscando participantes em locais em Pensilvânia.

Cidades em Pensilvânia

Texto oficial do estudo (Inglês)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lehigh Valley Hospital-Cedar Crest, Allentown
UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
e mais 53

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04267848

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Abramson Cancer Center of the University of Pennsylvania, Philadelphia
University of Pittsburgh Medical Center, Pittsburgh
WellSpan York Cancer Center, York

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
e mais 2

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07059884

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
e mais 7

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades de 40 a 75 · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

Bryn Mawr Hospital, Bryn Mawr
Penn State Milton S Hershey Medical Center, Hershey
Riddle Memorial Hospital, Media
e mais 6

RecrutandoFase 3

Idades 70 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
e mais 12

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT04181060

Empathic Communication Skills (ECS) Training

University of Pennsylvania (Data Collection Only), Philadelphia
Fox Chase Cancer Center (Data Collection Only), Philadelphia

RecrutandoVoluntários saudáveis bem-vindos

Idades de 18 a 100 · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05456841

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Bryn Mawr Hospital, Bryn Mawr
e mais 14

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06498635

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

Alliance Cancer Specialists, Sellersville

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 30 de set. de 2026 · NCT06765109

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

Penn State Milton S. Hershey Medical Center, Hershey

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT06881784

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Penn State Milton S. Hershey Medical Center-Penn State Cancer Institute ( Site 0059), Hershey
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0068), Lancaster

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06312137

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Alliance Cancer Specialists - Media, Media
Guthrie Medical Group, Sayre

RecrutandoFase 3

Idades de 18 a 100 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT05920356

A Registry for People With Lung Cancer

Thomas Jefferson University Hospital (Data Collection Only), Philadelphia
ALLEGHENY HEALTH NETWORK (Data Collection Only), Pittsburgh

RecrutandoEstudo observacional

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06424327

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

Research Site, Pittsburgh

RecrutandoFase 2

Idades de 18 a 95 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05061550

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

Hospital of the University of Pennsylvania, Philadelphia
West Penn Allegheny Health, Pittsburgh

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07100080

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de set. de 2026 · NCT06287775

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

St. Luke's University Health Network, Bethlehem
Allegheny Cancer Center, Pittsburgh
Reading Hospital - McGlinn Cancer Institute, West Reading

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06793215

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

USO - Alliance Cancer Specialists, PC, Horsham
Thomas Jefferson University, Sidney Kimmel Cancer Center - Clinical Trials Office, Philadelphia
UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 8 de set. de 2026 · NCT06119581

Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07012031

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Avenzo Therapeutics Recruiting Site, Philadelphia

RecrutandoFase 1/2

Idades de 18 a 75 · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07038343

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

Fox Chase Cancer Center, Philadelphia

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT07185997

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

St. Luke's Physician Group - St. Luke's Cancer Care Associates, Fountain Hill

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de set. de 2026 · NCT06712355

Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

Hospital of the University of Pennsylvania, Philadelphia

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07499674

Pemefolacianine for IMI of Lung Cancer

University of Pennsylvania, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 19 de ago. de 2026 · NCT07772895

A Study of Pembrolizumab With or Without Chemotherapy in Combination With Additional Treatments for Advanced Non-Small Cell Lung Cancer (NSCLC) (MK-3475-01G/KEYMAKER U01)

Abramson Cancer Center ( Site 0010), Philadelphia

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06731907

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Christiana Care Health System-Concord Health Center, Chadds Ford
Chambersburg Hospital, Chambersburg
Geisinger Medical Center, Danville
e mais 17

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05624996

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT06060613

Evaluate the Clinical Performance of the Flow Cytometry - FlowPath Lung Test as a Sensitive and Specific Non-invasive Diagnostic of Sputum Samples to Identify/Detect the Presence of Lung Cancer in High-risk Individuals Who Have Existing Lung Nodules, 6 to <30 mm in Diameter, Determined by LDCT.

Clinical Research Associates of Central Pennsylvania, DuBois

Recrutando

Idades de 50 a 80 · Todos os sexos · Atualizado em 16 de jul. de 2026 · NCT07168993

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de jul. de 2026 · NCT07315113

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 30 de jun. de 2026 · NCT06162221

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

Sidney Kimmel Cancer Center, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT07458347

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Allegheny General Hospital, Natrona Heights

RecrutandoFase 2

Idades de 18 a 70 · Todos os sexos · Atualizado em 26 de jun. de 2026 · NCT04614103

MOv19-BBz CAR T Cells in FRa+ Cancers

University of Pennsylvania, Philadelphia

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de jun. de 2026 · NCT07116057

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

UPMC Hillman Cancer Center, Pittsburgh

RecrutandoFase 1/2

Idades de 18 a 70 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT05361174

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

UPMC Altoona, Altoona
UPMC-Heritage Valley Health System Beaver, Beaver
UPMC Hillman Cancer Center at Butler Health System, Butler
e mais 37

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05642572

Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES

Penn Medicine University City, Philadelphia
Perelman Center for Advanced Medicine, Philadelphia
Penn Medicine Washington Square, Philadelphia

Recrutando

Idades de 35 a 89 · Todos os sexos · Atualizado em 2 de jun. de 2026 · NCT05968898

Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

RecrutandoVoluntários saudáveis bem-vindos

Idades de 50 a 77 · Todos os sexos · Atualizado em 29 de mai. de 2026 · NCT05679349

Telehealth Collaborative Care Model (CoCM) in Lung Cancer

Abramson Cancer Center at the University of Pennsylvania, Philadelphia

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 28 de mai. de 2026 · NCT07102147

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Fox Chase Cancer Center, Philadelphia

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de mai. de 2026 · NCT05800587

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.